Related Experiment Video
Updated: Dec 5, 2025

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
The deubiquitinase JOSD2 is a positive regulator of glucose metabolism
Lyudmila Krassikova1, Boxi Zhang1, Divya Nagarajan1
1Department of Physiology and Pharmacology, Biomedicum, Karolinska Institutet, Solnavägen 9, SE-171 65, Stockholm, Sweden.
Abstract:
Cancer cells undergo complex metabolic alterations. The mechanisms underlying the tuning of cancer metabolism are under active investigation. Here, we identify the uncharacterized deubiquitinase JOSD2 as a positive regulator of cancer cell proliferation by displaying comprehensive effects on glucose catabolism. We found that JOSD2 directly controls a metabolic enzyme complex that includes Aldolase A, Phosphofructokinase-1 and Phosphoglycerate dehydrogenase, in vitro and in vivo. Further, JOSD2 expression, but not a catalytically inactive mutant, deubiquitinates and stabilizes the enzyme complex, thereby enhancing their activities and the glycolytic rate. This represents a selective JOSD2 feature that is not shared among other Machado-Joseph disease DUBs or observed in nontransformed cells. JOSD2 deficiency displays cytostatic effects and reduces glycolysis in a broad spectrum of tumor cells of distinct origin and its expression correlates with poor prognosis in non-small cell lung cancer. Overall, our study provides evidence for a previously unknown biological mechanism in which JOSD2 integrates glucose and serine metabolism with potential therapeutic implications.
Insights
The deubiquitinase JOSD2 promotes cancer cell proliferation by enhancing glucose metabolism. JOSD2 stabilizes key enzymes, impacting tumor growth and offering potential therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Cancer cells exhibit significant metabolic reprogramming.
- Understanding the regulation of cancer metabolism is crucial for therapeutic development.
Purpose of the Study:
- To investigate the role of the deubiquitinase JOSD2 in cancer cell proliferation and metabolism.
- To elucidate the molecular mechanisms by which JOSD2 influences metabolic pathways.
Main Methods:
- In vitro and in vivo assays to assess JOSD2's enzymatic activity and cellular effects.
- Analysis of JOSD2's interaction with metabolic enzyme complexes.
- Correlation studies between JOSD2 expression and patient prognosis.
Main Results:
- JOSD2 acts as a positive regulator of cancer cell proliferation.
- JOSD2 deubiquitinates and stabilizes a metabolic enzyme complex including Aldolase A, Phosphofructokinase-1, and Phosphoglycerate dehydrogenase.
- JOSD2 enhances glycolytic rate and its deficiency shows cytostatic effects across various tumor types.
- JOSD2 expression correlates with poor prognosis in non-small cell lung cancer.
Conclusions:
- JOSD2 integrates glucose and serine metabolism, promoting cancer cell proliferation.
- JOSD2's specific role in stabilizing metabolic enzymes presents a potential therapeutic vulnerability.
- Targeting JOSD2 may offer a novel strategy for cancer treatment.
More Related Videos
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Glucose Absorption Into the Small Intestine
Regulation of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

